Search Results - robert+kauffman

2 Results Sort By:
SARS-CoV-2 Neutralizing Human Monoclonal Antibodies
­ Application Monoclonal antibodies to SARS-CoV2 for use in COVID-19 diagnostics and therapeutics. Key Benefits Demonstrably neutralizing, important for therapeutic mAbs. Most bind both RBG and stalk portion of spike protein, useful in case SARS-CoV2 strains develop variation in RBD. Market Summary Coronavirus (COVID-19) is an infectious...
Published: 10/17/2024   |   Inventor(s): Jens Wrammert, Carl Davis, Mehul Suthar, Robert Kauffman
Keywords(s): Antibody, COVID19, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Therapeutics
Serological Test for SARS-CoV-2
­ Application Clinical assay for detecting SARS-CoV-2 neutralizing antibodies. Key Benefits Highly specific and sensitive. Fewer false positives than commercially available tests. Market Summary SARS-CoV-2 is currently causing a devastating pandemic and there is a pressing need to understand the dynamics, specificity, and neutralizing...
Published: 7/30/2024   |   Inventor(s): Rafi Ahmed, Mehul Suthar, John Roback, Jens Wrammert, Robert Kauffman
Keywords(s): Assay, COVID19, Microbiology/Infectious Diseases, Vaccine
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Drug Discovery, TechPub Algolia > Micro and Nanotechnology